Snowball logo
logo
VIRP_logo

Virbac SA

331.500.00  (0%)
Estimate
P/E
18.4
EPS
18.01
Beta
0.776
Forecast
P/E (FWD)
14.9
EPS (FWD)
22.3
Dividends
Dividend yield
0.44%
Annual payout
1.45
Next ex. div date
July 2, 27
Payout
7.83%
Div.rating
About the company
Ticker
VIRP
ISIN
FR0000031577
Country
France
Sector (GICS)
Healthcare
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx soft chews formulated with ursolic acid that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, immunology, nutrition, petfood, and pharmaceutical products. In addition, the company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Frequently asked questions

What sector does Virbac SA (VIRP) operate in?

Virbac SA belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Virbac SA (VIRP) current stock price?

As of the latest data, Virbac SA stock price is €331.50, with a previous close of €331.50.

What is Virbac SA (VIRP) current market capitalization?

Virbac SA market cap is approximately 2.78 billion.

What is Virbac SA (VIRP) Earnings Per Share (EPS)?

The trailing EPS is €18.01, and the forward EPS is €22.30.

What is Virbac SA (VIRP) Price-to-Earnings (P/E) ratio?

Virbac SA current P/E ratio is 18.41, with a forward P/E of 14.87.

Does Virbac SA (VIRP) pay dividends?

Yes. Virbac SA pays annual dividends with an annualized yield of 0.44% and an estimated annual payout of €1.45 per share.

When is the next ex-dividend date for Virbac SA (VIRP)?

The next ex-dividend date is scheduled for July 02, 2027.

When is Virbac SA (VIRP) next earnings report?

Virbac SA is expected to release its next earnings report on June 30, 2026.

What is Virbac SA (VIRP) beta (volatility) score?

Virbac SA has a beta of 0.776, indicating lower volatility than the overall market.